PAVmed (PAVM) Enterprise Value (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.70% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | -50.91% |
| Mar 31, 2025 | -50.46% |
| Jun 30, 2024 | 31.47% |
| Mar 31, 2024 | 122.81% |
| Dec 31, 2023 | 894.53% |
| Sep 30, 2023 | 115.78% |
| Jun 30, 2023 | 60.53% |
| Mar 31, 2023 | 14.17% |
| Dec 31, 2022 | 48.55% |
| Sep 30, 2022 | 18.70% |
| Jun 30, 2022 | 0.45% |
| Mar 31, 2022 | 22.81% |
| Dec 31, 2021 | -60.93% |
| Sep 30, 2021 | 16.19% |
| Jun 30, 2021 | 13.13% |
| Mar 31, 2021 | -158.81% |
| Dec 31, 2020 | -93.24% |
| Sep 30, 2020 | -18.58% |
| Jun 30, 2020 | 14.03% |
| Mar 31, 2020 | -41.66% |
| Dec 31, 2019 | -52.30% |
| Sep 30, 2019 | 36.31% |
| Jun 30, 2019 | -64.19% |
| Mar 31, 2019 | 47.32% |
| Dec 31, 2018 | 10.17% |
| Sep 30, 2018 | 16.75% |
| Jun 30, 2018 | -208.75% |
| Mar 31, 2018 | -136.52% |
| Dec 31, 2017 | 50.67% |
| Sep 30, 2017 | -3,692.05% |
| Jun 30, 2017 | 90.94% |
| Mar 31, 2017 | -54.63% |
| Dec 31, 2016 | 67.26% |
| Sep 30, 2016 | 40.83% |
| Jun 30, 2016 | -1,180.58% |
| Mar 31, 2016 | 69.23% |
| Dec 31, 2015 | 45.79% |
| Sep 30, 2015 | -171.35% |